WaveMan
WaveMan · Company
CNO · Cno Financial Group, Inc.
> Search tickers & screens ⌘K
LIVE
← All companies

CNO CNO Financial (CNO) Insider Trading, Ownership & Congress Trades

Insurance · Accident & health insurance · CIK 0001224608
Quote by TradingView
Form 144 · 8
Insider buyers, 180 days
0
House members buying, 1 year
0
STOCK Act, US House only, disclosed up to 45 days after the trade
Funds added, last quarter
0
13F, latest reported quarter
Conversions, 180 days
7
Codes C/M, not in net · $1.6M priced

What the filings say about CNO

Insiders, 180 days
-$7.8M net sold
5 sellers · 67% of sales under a 10b5-1 plan
Congress, 1 year
No trades
Last one: sale, 2025-06-11
Planned sales (Form 144), 90 days
$2.6M
8 notices

CNO Financial insider trades (Form 4)

Form 4 buys and sells (codes P and S). Grants, option exercises and conversions excluded.

Over the last 180 days, CNO Financial Group, Inc. insiders sold a net $7.8M of stock across 135 Form 4 purchases and sales, with no insider buying. Source: SEC Form 4 filings, as of 2026-10-28.

Insider
Filed
Shares
Value
Since filing
Williams Jeremy D.
Chief Actuary
SELL
2026-09-16 SEC
3,240
$180.5K
-2.5%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 15, 2026.
  • The trade is 5.2% of the 62,163 shares held after it.
  • 2 other insiders sold within 30 days.
Insider activity: Chief Actuary Williams Jeremy D. sold about $180.5K of CNO under a 10b5-1 plan on Sep 16, 2026; 2 other insiders sold within 30 days.
Williams Jeremy D.
Chief Actuary
SELL
2026-09-16 SEC
1,122
$62.5K
-2.5%
Context
  • 1 earlier Form 4 trade (code P or S) here by this insider (1 sale), the last on Sep 15, 2026.
  • The trade is 1.8% of the 61,041 shares held after it.
  • 2 other insiders sold within 30 days.
Insider activity: Chief Actuary Williams Jeremy D. sold about $62.5K of CNO under a 10b5-1 plan on Sep 16, 2026; 2 other insiders sold within 30 days.
Williams Jeremy D.
Chief Actuary
SELL
2026-09-16 SECtraded 2026-09-15
4,420
$244.3K
-2.5%
Context
  • First Form 4 purchase or sale (code P or S) here by this insider on our record.
  • The trade is 7.1% of the 62,163 shares held after it.
  • 2 other insiders sold within 30 days.
Insider activity: Chief Actuary Williams Jeremy D. sold about $244.3K of CNO under a 10b5-1 plan on Sep 15, 2026; 2 other insiders sold within 30 days.
Linnenbringer Jeanne L.
Chief Operations Officer
SELL
2026-09-02 SEC
3,919
$216.0K
-4.1%
Context
  • 13 earlier Form 4 trades (code P or S) here by this insider (13 sales), the last on Sep 1, 2026.
  • The trade is 15.0% of the 26,209 shares held after it.
  • 2 other insiders sold within 30 days.
Insider activity: Chief Operations Officer Linnenbringer Jeanne L. sold about $216.0K of CNO under a 10b5-1 plan on Sep 2, 2026; 2 other insiders sold within 30 days.
DeToro Karen J.
President, Worksite Division
SELL
2026-09-02 SEC
5,964
$328.7K
-4.1%
Context
  • 7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Sep 1, 2026.
  • The trade is 16.4% of the 36,450 shares held after it.
  • 2 other insiders sold within 30 days.
Insider activity: President, Worksite Division DeToro Karen J. sold about $328.7K of CNO under a 10b5-1 plan on Sep 2, 2026; 2 other insiders sold within 30 days.
135 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
See all insider buying · insider selling
Showing the latest few. to see 130 more transactions and use the screener and CSV export. We store only your email; there is no password.
Seven facts, ranked against the sector · Rank is not a forecast
Insiders
net -$7.8M over 180 days
-$2.6M over 90 days
below 65% of Insurance
Congress
no House purchase disclosed in the last 12 months
Funds
under five funds report holding it
Revenue
+0.9% year over year
below 77% of Insurance
Margin
5.1% net margin
below 68% of Insurance
Buybacks
$134.2M repurchased, FY to 2026-06-30
below 52% of Insurance
Short interest
2.9% of the float short (float per yahoo 2026-10-26) · 2.1 days to cover · settled 2026-09-30
more than 50% of Insurance
What changed in the last 30 days
Nothing new filed in the last 30 days

Watch CNO

A free account keeps a watchlist and can send one email a day when insiders, funds or Congress file on the names in it. No password and no card.

The year, with the filings on it
Total return over 12 months. Each marker is a filing; hover or tap one for the detail.
+37.7%12M
-1%+14%+29%+44%2025-102025-122026-022026-042026-062026-082026-10 2026-06-30 · Bhojwani Gary C. sold $2.3M2026-06-30 · Bhojwani Gary C. sold $2.2M2025-11-10 · Johnson Eric R. sold $2.0M2026-02-17 · Bhojwani Gary C. sold $2.0M2026-02-18 · Bhojwani Gary C. sold $1.9M2026-02-18 · Zimpfer Matthew J. sold $1.5M2026-02-12 · Zimpfer Matthew J. sold $1.3M2026-01-02 · Bhojwani Gary C. sold $1.3M2025-11-20 · Bhojwani Gary C. sold $1.3M2026-02-17 · Zimpfer Matthew J. sold $1.0M2026-03-19 · Goldberg Scott L. sold $442.1K2026-03-20 · Goldberg Scott L. sold $437.3K2026-08-31 · DeToro Karen J. sold $412.3K2026-09-01 · DeToro Karen J. sold $410.5K2026-09-02 · DeToro Karen J. sold $328.7K2026-06-11 · Tarasi Rocco F. III sold $287.5K2026-08-31 · Linnenbringer Jeanne L. sold $275.5K2025-12-15 · TARASI ROCCO F III sold $255.7K2026-09-15 · Williams Jeremy D. sold $244.3K2026-06-02 · Tarasi Rocco F. III sold $226.0K2026-09-01 · Linnenbringer Jeanne L. sold $222.2K2026-09-02 · Linnenbringer Jeanne L. sold $216.0K2026-09-16 · Williams Jeremy D. sold $180.5K2026-06-10 · Tarasi Rocco F. III sold $162.1K2025-12-15 · TARASI ROCCO F III sold $139.8K2026-02-17 · Franzese Yvonne K. sold $129.5K2026-02-17 · Franzese Yvonne K. sold $129.5K2026-02-17 · Franzese Yvonne K. sold $129.5K2025-11-24 · Franzese Yvonne K. sold $123.0K2026-08-31 · DeToro Karen J. sold $103.0K2026-09-01 · DeToro Karen J. sold $100.5K2026-07-01 · Tarasi Rocco F. III sold $97.0K2026-08-31 · Linnenbringer Jeanne L. sold $85.2K2026-09-16 · Williams Jeremy D. sold $62.5K2026-09-16 · JEREMY WILLIAMS filed to sell $243.0K2026-09-15 · JEREMY WILLIAMS filed to sell $244.3K2026-09-02 · JEANNE LINNENBRINGER filed to sell $216.0K2026-09-02 · KAREN DETORO filed to sell $328.7K2026-09-01 · KAREN DETORO filed to sell $511.0K2026-09-01 · JEANNE LINNENBRINGER filed to sell $222.2K2026-08-31 · JEANNE LINNENBRINGER filed to sell $360.7K2026-08-31 · KAREN DETORO filed to sell $515.4K2026-07-01 · ROCCO TARASI III filed to sell $97.0K2026-06-30 · GARY BHOJWANI filed to sell $4.4M
Insider sellForm 144 (planned sale)
Indexed to 100, dividend-adjusted, not a price chart. When a name files heavily, the largest trades are drawn first.

Who owns CNO: institutional holders (13F)

13F holdings, latest reported quarter
SEC 13F
No reported 13F holders

No fund above the reporting threshold listed this stock last quarter. That is a fact, not missing data.

Congress trades in CNO

STOCK Act disclosures, US House only, filed up to 45 days after the trade
Lisa McClain
Sold 2025-06-11 · disclosed 63 days later
$1,001 - $15,000
Lisa McClain
Bought 2025-06-09 · disclosed 65 days later
$1,001 - $15,000
Jefferson Shreve
Sold 2025-05-12 · disclosed 41 days later
$15,001 - $50,000
All stocks members of Congress are buying · Every member's trades

Activist and 5% holders (13D/13G)

No 5%+ ownership filings
Nobody has filed for crossing 5%. That is a fact, not missing data.

CNO planned insider sales (Form 144)

Notice of intent to sell, filed before any sale
JEREMY WILLIAMS
Filed 2026-09-16
$243.0K
JEREMY WILLIAMS
Filed 2026-09-15
$244.3K
JEANNE LINNENBRINGER
Filed 2026-09-02
$216.0K
KAREN DETORO
Filed 2026-09-02
$328.7K
KAREN DETORO
Filed 2026-09-01
$511.0K
Executive pay vs shareholder return · Gary C. Bhojwani
CEO pay, headline and as actually paid, against the company's return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$11.2M
$16.2M
$3.3M
+113%
+101%
2024
$10.4M
$18.3M
$3.0M
+84%
+90%
2023
$9.8M
$11.1M
$2.7M
+35%
+58%
2022
$8.8M
$7.4M
$3.0M
+8%
+51%
2021
$8.9M
$13.9M
$2.5M
+10%
+37%
Tagged by the company under SEC Item 402(v). Returns are cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
Insiders have filed to sell, before selling.
The record shows a net $7.8M sold by insiders over 180 days, $2.6M in planned Form 144 sales. Each figure is a federal filing, dated the day it went public.
Backtest this pattern Open the screener
Same sector, ranked by filing activity
Sector by SEC SIC code
GSHDDGICAPLMRALHCCRVLHGTYKNSLAFLTRVMKLOSCRGL

CNO financials

Revenue growth
+0.9%
XBRL, annual
Net margin
5.1%
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
$4.6B
four quarters, 2025-07-01 to 2026-06-30
Net margin, TTM
+6.0%
net income over revenue, 2025-07-01 to 2026-06-30
Free cash flow, TTM
n/a
capex not filed for the four quarters
Debt to equity
0.39x
long-term debt only, 2020-09-30 (69 months older than the period end); equity 2026-06-30
Cash flow to debt
0.70x
TTM operating cash flow over long-term debt only, 2020-09-30 (69 months older than the period end)
Return on equity
+10.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets
+0.7%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on invested capital
+17.0%
operating income after a 21.4% effective tax rate, over long-term debt only, 2020-09-30 (69 months older than the period end) plus average of 2025-06-30 and 2026-06-30 minus cash
Return on capital employed
n/a
assets or current liabilities not filed
P/E, trailing
18.63x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
Enterprise value
$5.4B
market value at close 2026-10-26 on 2026-07-30 shares, plus long-term debt only, 2020-09-30 (69 months older than the period end), minus cash 2018-12-31
FCF yield
n/a
capex not filed for the four quarters
PEG, trailing
n/a
trailing EPS growth -1%, PEG needs growth
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.
Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
2025-122024-122023-122022-12
Revenue$4.5B$4.4B$4.1B$3.6B
Operating income$553.2M$550.8M$459.5M$466.7M
Net income$229.3M$420.8M$276.5M$630.6M
EPS (diluted)2.303.892.405.36
Operating cash flow$675.7M$627.7M$582.9M$495.4M
Buybacks$331.4M$300.2M$166.1M$190.1M
Dividends paid$66.2M$67.7M$68.1M$64.8M
SEC XBRL, fiscal years, as known on 2026-10-28

CNO Stock Sonar score 6/7 axes

Find similar shapesCompare

CNO ranks highest on risk and compliance (66th percentile) and financial health (47th), and lowest on institutional and government (1st), among Insurance peers.

ProfitHealthGrowthInsidersInstitutionsRisk
Profitability
44
Inputs
  • Return on equity+10.9% · 35 pct, sector of 116
  • Return on assets+0.7% · 30 pct, sector of 122
  • Return on invested capital+17.0% · 66 pct, universe of 1,069
  • Return on capital employedassets or current liabilities not filed
Financial health
47
Inputs
  • Debt to equity0.39x · 38 pct, sector of 104
  • Cash flow to debt0.70x · 55 pct, sector of 97
Growth
23
Inputs
  • Revenue growth, YoY+0.9% · 23 pct, sector of 134
  • Backlog growth, YoYno backlog line filed, or no year-earlier backlog
Insider conviction
18
Inputs
  • Net Form 4 buying (codes P and S), 180d-$5.2M · 36 pct, sector of 100
  • Insider buyers, 180d0 · 0 pct, sector of 101
Institutional and government
0
Inputs
  • Funds adding, latest quarterfewer than five funds report holding it
  • Congress net buyers, 365dno Congress trades in 365 days
  • Federal contracts, 180dno federal contracts in 180 days
  • Lobbying spend, 4 quarters$10K · 0 pct, sector of 35
Risk and compliance
66
Inputs
  • Short interest, % of float+2.9% · 60 pct, sector of 138
  • Recalls per $1B revenue, 3ynot measured for this sector, almost no peer has an event
  • EPA cases per $1B revenue, 5ynot measured for this sector, almost no peer has an event
  • New text in Risk Factors, latest 10-K+7.0% · 72 pct, sector of 110
1 not measured: US patents
  • US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet

6 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored

CNO filings, in plain words

Are CNO Financial insiders buying or selling CNO?

In the 180 days to 2026-10-28, CNO Financial insiders were net sellers, a net $7.8M across purchases and sales reported on Form 4, by 5 sellers.

Have members of Congress traded CNO?

Yes, but not in the year to 2026-10-28; the latest on record is a sale by Lisa McClain dated 2025-06-11.

Are there planned insider sales of CNO?

Yes. 8 Form 144 notices of planned insider sales were filed in the 90 days to 2026-10-28, covering $2.6M of stock; the latest, by JEREMY WILLIAMS, was filed 2026-09-16.

Read the full summary

In the 180 days to 2026-10-28, CNO Financial insiders were net sellers of CNO, a net $7.8M across purchases and sales reported on Form 4 by 5 sellers. 67% of the 18 insider sales were made under a Rule 10b5-1 plan; the rest were not flagged as planned. Members of Congress have disclosed trades in CNO, none in the last year; the latest on record is a sale by Lisa McClain dated 2025-06-11. Insiders filed 8 Form 144 notices of intent to sell in the 90 days to 2026-10-28, covering $2.6M of stock. Each figure is counted from SEC and House filings as of 2026-10-28, dated the day the filing was made public.

Explore insider trading and ownership data

Every company we track, ranked by each kind of filing
Insider buyingInsider sellingCongress stock tradesActivist 13D stakesForm 144 planned salesCEO pay vs performanceAll companies